IRF1 and neoplasm: This finding is consistent with a detailed examination of the ‘critical region’ on 5q affected in MDS and AML patients, which contains crucial genes with tumor suppressing potential, such as interleukin 3 (IL-3), IL-4, IL-5, and CSF2 [74], which IRF-1 maps closely [70].